Issuance of the Fourth Series Stock Acquisition Rights
First written in FY2020-Q2. 3 of 6 entries say "Advanced", first in FY2020. Latest entry: FY2026.
The whole theme swung hardest in 2026: 1 of 9 companies on the "Worse" side.
1 other company's latest entry also says "Other".
- FY2026Update to Outstanding Stock OptionsAnnual report
「Outstanding and unexercised 54,000 － 15,000」
The company has disclosed 54,000 unexercised shares under the 2020 stock options; one of the 2021 stock options expired in full, while 15,000 shares remained unexercised under the other. - FY2024Update to Stock Option ExercisesAnnual report
「Other (exercise of stock options) 23,100 33,946」
During the fiscal year, the company disclosed the disposal of 23,100 treasury shares through the exercise of stock options, for total disposal proceeds of ¥33.946 million. - FY2022-Q1AdvancedAnnual report
「24 August 2021 Company employees 1 Number of share acquisition rights (units)* 50 Class, details and number of shares underlying the share acquisition rights (shares)* 5,000 common shares Exercise period of the share acquisition rights* From 9 September 2023 to 8 September 2026」
The company has disclosed that the seventh series of share acquisition rights approved on 24 August 2021 was granted to 1 employee, comprising 50 rights representing 5,000 common shares, with an exercise period from 9 September 2023 to 8 September 2026. - FY2021AdvancedAnnual report
「(Resolution of the Board of Directors dated 25 May 2021) A resolution was passed on 25 May 2021, under the Companies Act, to grant share acquisition rights to the company’s directors serving on 25 May 2021, excluding directors who are Audit and Supervisory Committee members and outside directors. Number of share acquisition rights (units)* 200 Class, details and number of shares underlying the share acquisition rights (shares)* 20,000 common shares」
The company has disclosed a resolution to grant 200 share acquisition rights representing 20,000 common shares to 3 executive directors. - FY2020AdvancedAnnual report
「Resolution of the Board of Directors held on 14 August 2020 Number of share acquisition rights 270 Number of shares underlying the share acquisition rights 27,000 common shares Exercise period From 15 August 2025 to 14 August 2028」
The company has additionally disclosed 270 share acquisition rights and 27,000 common shares for 23 employees. - FY2020-Q2First statedAnnual report
「Fourth Series of Share Acquisition Rights pursuant to a resolution of the Board of Directors held on 19 August 2019 Number of share acquisition rights 125 (12,500 common shares)」
The company has disclosed details of the fourth series of share acquisition rights pursuant to the resolution of the Board of Directors held on 19 August 2019: 125 rights representing 12,500 common shares.